Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial Roseane P. Medeiros; Norah A. Terrault; Daniel F. Mazo; Claudia P. Oliveira; Jennifer Dodge; Patricia M. Zitelli; Marta H. Lopes; Flair J. Carrilho; Mário G. Pessoa;

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver Cristiane A. Villela-Nogueira; Maria Lúcia Gomes Ferraz; Mário Guimarães Pessoa; Francisco José Dutra Souto; Letícia Cancella Nabuco; Henrique Sérgio Moraes Coelho; Ezequiel Ridruejo; Marcelo Silva; Paulo Lisboa Bittencourt; Carlos Eduardo Brandão-Mello;

Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico JC Jiménez-Mendoza; FE Rivera-López; MF González-Lara; RD Valdez-Echeverría; GE Castro-Narro; A Tore; LF Uscanga-Domínguez; C Moctezuma-Velázquez;